Osa Eisele MD, MPH, possesses extensive experience in clinical safety and pharmacovigilance within the biopharmaceutical industry. Currently, Osa serves as Executive Director, Representation in Clinical Research at Amgen, overseeing various aspects of oncology therapeutic area safety, including the roles of Oncology Therapeutic Area Safety Head and Gen Med Safety Therapeutic Area Head. Previously, Osa held the position of Senior Director, Head of Clinical Safety/Pharmacovigilance at Mesoblast. Additionally, Osa worked at Allergan as a Medical Director and Medical Safety Physician, with a focus on risk management and epidemiology, and also served as an Epidemiology Consultant. Osa began a research-centric role as Principal Investigator at SDSU Research Foundation.